Traded Dec 1, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Oct 31, 2025 · Filed Nov 3, 2025
The CFO of Dorman Products sold $419K of Dorman Products shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$418,521
Shares × reported transaction price
4 days after results of Oct 27, 2025, 117 days before results of Feb 25, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.5% | +1.1% | +0.4% |
| 30 days | −3.7% | +1.4% | −5.1% |
| 90 days | −3.5% | +3.0% | −6.5% |
| 180 days | −15.5% | +6.3% | −21.9% |
Past results only. Not a forecast.
Traded Dec 1, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Dec 1, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Dec 1, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.